HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

<h4>Background</h4>Human Immunodeficiency virus type-1 (HIV) entry into target cells involves binding of the viral envelope (Env) to CD4 and a coreceptor, mainly CCR5 or CXCR4. The only currently licensed HIV entry inhibitor, maraviroc, targets CCR5, and the presence of CXCX4-using strai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martin Mulinge, Morgane Lemaire, Jean-Yves Servais, Arkadiusz Rybicki, Daniel Struck, Eveline Santos da Silva, Chris Verhofstede, Yolanda Lie, Carole Seguin-Devaux, Jean-Claude Schmit, Danielle Perez Bercoff
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fa11ab77848e4cfbb4d04d1cf5e57b17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa11ab77848e4cfbb4d04d1cf5e57b17
record_format dspace
spelling oai:doaj.org-article:fa11ab77848e4cfbb4d04d1cf5e57b172021-11-18T07:46:24ZHIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].1932-620310.1371/journal.pone.0060566https://doaj.org/article/fa11ab77848e4cfbb4d04d1cf5e57b172013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667426/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Human Immunodeficiency virus type-1 (HIV) entry into target cells involves binding of the viral envelope (Env) to CD4 and a coreceptor, mainly CCR5 or CXCR4. The only currently licensed HIV entry inhibitor, maraviroc, targets CCR5, and the presence of CXCX4-using strains must be excluded prior to treatment. Co-receptor usage can be assessed by phenotypic assays or through genotypic prediction. Here we compared the performance of a phenotypic Env-Recombinant Viral Assay (RVA) to the two most widely used genotypic prediction algorithms, Geno2Pheno[coreceptor] and webPSSM.<h4>Methods</h4>Co-receptor tropism of samples from 73 subtype B and 219 non-B infections was measured phenotypically using a luciferase-tagged, NL4-3-based, RVA targeting Env. In parallel, tropism was inferred genotypically from the corresponding V3-loop sequences using Geno2Pheno[coreceptor] (5-20% FPR) and webPSSM-R5X4. For discordant samples, phenotypic outcome was retested using co-receptor antagonists or the validated Trofile® Enhanced-Sensitivity-Tropism-Assay.<h4>Results</h4>The lower detection limit of the RVA was 2.5% and 5% for X4 and R5 minority variants respectively. A phenotype/genotype result was obtained for 210 samples. Overall, concordance of phenotypic results with Geno2Pheno[coreceptor] was 85.2% and concordance with webPSSM was 79.5%. For subtype B, concordance with Geno2pheno[coreceptor] was 94.4% and concordance with webPSSM was 79.6%. High concordance of genotypic tools with phenotypic outcome was seen for subtype C (90% for both tools). Main discordances involved CRF01_AE and CRF02_AG for both algorithms (CRF01_AE: 35.9% discordances with Geno2Pheno[coreceptor] and 28.2% with webPSSM; CRF02_AG: 20.7% for both algorithms). Genotypic prediction overestimated CXCR4-usage for both CRFs. For webPSSM, 40% discordance was observed for subtype A.<h4>Conclusions</h4>Phenotypic assays remain the most accurate for most non-B subtypes and new subtype-specific rules should be developed for non-B subtypes, as research studies more and more draw conclusions from genotypically-inferred tropism, and to avoid unnecessarily precluding patients with limited treatment options from receiving maraviroc or other entry inhibitors.Martin MulingeMorgane LemaireJean-Yves ServaisArkadiusz RybickiDaniel StruckEveline Santos da SilvaChris VerhofstedeYolanda LieCarole Seguin-DevauxJean-Claude SchmitDanielle Perez BercoffPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 5, p e60566 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Martin Mulinge
Morgane Lemaire
Jean-Yves Servais
Arkadiusz Rybicki
Daniel Struck
Eveline Santos da Silva
Chris Verhofstede
Yolanda Lie
Carole Seguin-Devaux
Jean-Claude Schmit
Danielle Perez Bercoff
HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
description <h4>Background</h4>Human Immunodeficiency virus type-1 (HIV) entry into target cells involves binding of the viral envelope (Env) to CD4 and a coreceptor, mainly CCR5 or CXCR4. The only currently licensed HIV entry inhibitor, maraviroc, targets CCR5, and the presence of CXCX4-using strains must be excluded prior to treatment. Co-receptor usage can be assessed by phenotypic assays or through genotypic prediction. Here we compared the performance of a phenotypic Env-Recombinant Viral Assay (RVA) to the two most widely used genotypic prediction algorithms, Geno2Pheno[coreceptor] and webPSSM.<h4>Methods</h4>Co-receptor tropism of samples from 73 subtype B and 219 non-B infections was measured phenotypically using a luciferase-tagged, NL4-3-based, RVA targeting Env. In parallel, tropism was inferred genotypically from the corresponding V3-loop sequences using Geno2Pheno[coreceptor] (5-20% FPR) and webPSSM-R5X4. For discordant samples, phenotypic outcome was retested using co-receptor antagonists or the validated Trofile® Enhanced-Sensitivity-Tropism-Assay.<h4>Results</h4>The lower detection limit of the RVA was 2.5% and 5% for X4 and R5 minority variants respectively. A phenotype/genotype result was obtained for 210 samples. Overall, concordance of phenotypic results with Geno2Pheno[coreceptor] was 85.2% and concordance with webPSSM was 79.5%. For subtype B, concordance with Geno2pheno[coreceptor] was 94.4% and concordance with webPSSM was 79.6%. High concordance of genotypic tools with phenotypic outcome was seen for subtype C (90% for both tools). Main discordances involved CRF01_AE and CRF02_AG for both algorithms (CRF01_AE: 35.9% discordances with Geno2Pheno[coreceptor] and 28.2% with webPSSM; CRF02_AG: 20.7% for both algorithms). Genotypic prediction overestimated CXCR4-usage for both CRFs. For webPSSM, 40% discordance was observed for subtype A.<h4>Conclusions</h4>Phenotypic assays remain the most accurate for most non-B subtypes and new subtype-specific rules should be developed for non-B subtypes, as research studies more and more draw conclusions from genotypically-inferred tropism, and to avoid unnecessarily precluding patients with limited treatment options from receiving maraviroc or other entry inhibitors.
format article
author Martin Mulinge
Morgane Lemaire
Jean-Yves Servais
Arkadiusz Rybicki
Daniel Struck
Eveline Santos da Silva
Chris Verhofstede
Yolanda Lie
Carole Seguin-Devaux
Jean-Claude Schmit
Danielle Perez Bercoff
author_facet Martin Mulinge
Morgane Lemaire
Jean-Yves Servais
Arkadiusz Rybicki
Daniel Struck
Eveline Santos da Silva
Chris Verhofstede
Yolanda Lie
Carole Seguin-Devaux
Jean-Claude Schmit
Danielle Perez Bercoff
author_sort Martin Mulinge
title HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
title_short HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
title_full HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
title_fullStr HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
title_full_unstemmed HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
title_sort hiv-1 tropism determination using a phenotypic env recombinant viral assay highlights overestimation of cxcr4-usage by genotypic prediction algorithms for crf01_ae and crf02_ag [corrected].
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/fa11ab77848e4cfbb4d04d1cf5e57b17
work_keys_str_mv AT martinmulinge hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT morganelemaire hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT jeanyvesservais hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT arkadiuszrybicki hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT danielstruck hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT evelinesantosdasilva hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT chrisverhofstede hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT yolandalie hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT caroleseguindevaux hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT jeanclaudeschmit hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
AT danielleperezbercoff hiv1tropismdeterminationusingaphenotypicenvrecombinantviralassayhighlightsoverestimationofcxcr4usagebygenotypicpredictionalgorithmsforcrf01aeandcrf02agcorrected
_version_ 1718423011364700160